Revisiting the Cardiac Safety of Dose-Dense Chemotherapy: Encouraging Outcomes From Long-Term Follow-Up.

Int J Heart Fail · 2025 · PMC12160050 · PMID 40519708

Europe PMC DOI

hedged sentence

0.3050

closest p · 6.1× alpha

0.3050

boldest claim

The sentences

did not reach statistical significancep=0.305not close (p > 0.1)

The mortality rate was 31.8% in the dose-dense group and 43.9% in the conventional group; however, this difference did not reach statistical significance (p=0.305).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.